CARR vs EDIT · P/E 43, rev $5.15B vs rev $32.3M
Carrier Global Corp (CARR) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CARR and EDIT stock pages for the full models.
Not investment advice.